HBM Healthcare Investments (Cayman) Ltd., 10% Owner at Nabriva Therapeutics Plc (NBRV), sold 97,089 shares at $10.50 ($1.0M) on 2017-07-12, disclosed to the SEC on 2017-07-13.
Open-market sale of $1.0M NBRV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.52 | 3,521 | $37K | 3.6% |
| 2 | $10.50 | 13,740 | $144K | 14.1% |
| 3 | $10.54 | 39,914 | $421K | 41.1% |
| 4 | $10.54 | 39,914 | $421K | 41.1% |
| Total | $10.53 avg | 97,089 | $1.0M | 100% |
| Filing → |
| NBRV | SELL | 2017-09-14 | $598K | — | Filing → |
| NBRV | SELL | 2017-09-05 | $6K | — | Filing → |
| NBRV | SELL | 2017-08-09 | $208K | — | Filing → |